Would you be interested in the Business Strategies, Competitive Strengths and Key Risks?

Log in or Become a UTRADE Client Now

Latest IPO

Competitive Margin Interest Rates $0 Handling Fee on Cash Applications for New Self-Serviced Clients # Login to Subscribe
Planned Offering Offering Closing Date Settlement Refund / Grey Market Trading
2021

APR

MAY
1617181920212223242526272829300102030405
IPO Calendar
Planned IPOs
Stock Offer Period Trading Price（HKD） BoardLot IndicativeInterest Rate UOBKH'sClosing Date Sponsor(s) Oversubscription
IPO Calendar
 9961Trip.com-S 08/04/202113/04/2021 19/04/2021 333.0333.0 50 2.28% 12/04/2021

CICC

Goldman Sachs

JP Morgan

Day 1：>3x

Day 2：>4.2x

Day 3：>6.04x
Planned IPOs *
[Planned]
Zhaoke Ophthalmology Passed PHIP on 6 Apr N/A N/A N/A N/A N/A

Goldman Sachs*

Jefferies Group*

 -
[Planned]
ByteDance N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
XiaoDian N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Brii Bioscience Q2* N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

 -
[Planned]
GOGOX N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Medlive Technology Application Submitted* Q2* N/A N/A N/A N/A

Goldman Sachs*

Haitong*

 -
[Planned]
Qdama N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Medbanks N/A 2nd half of the year* N/A N/A N/A N/A

Morgan Stanley*

CICC*

Haitong*

 -
[Planned]
ESCO N/A Q4* N/A N/A N/A N/A

N/A

 -
[Planned]
APM Ｍonaco N/A 2021* N/A N/A N/A N/A

Morgan Stanley*

CICC*

 -
[Planned]
Abbisko N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
NIO N/A 2021* N/A N/A N/A N/A

Credit Suisse*

Morgan Stanley*

 -
[Planned]
XPeng N/A 2021* N/A N/A N/A N/A

JP Morgan*

BoA*

 -
[Planned]
Li Auto N/A 2021* N/A N/A N/A N/A

Goldman Sachs*

UBS*

 -
[Planned]
YiSheng Biopharma Application Submitted* 2021* N/A N/A N/A N/A

Morgan Stanley*

Haitong*

 -
[Planned]
Novotech N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
ECARX N/A 2nd half of the year* N/A N/A N/A N/A

Morgan Stanley*

UBS*

 -
[Planned]
Stroke Care Application submitted* Q2* N/A N/A N/A N/A

Goldman Sachs*

CITIC*

 -
[Planned]
CARsgen Application submitted* N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

 -
[Planned]
Weibo N/A 2nd half of the year* N/A N/A N/A N/A

Goldman Sachs*

UBS*

CLSA*

 -
[Planned]
Yuexiu Services Application submitted* N/A N/A N/A N/A N/A

ABCI*

CCBI*

CSC*

Yuexiu Capital*

 -
[Planned]
SF RELT N/A First half of 2021* N/A N/A N/A N/A

DBS*

 -
[Planned]
Betta Pharmaceuticals N/A First half of 2021* N/A N/A N/A N/A

Goldman Sachs*

UBS*

CITIC*

 -
[Planned]
Visen Pharma N/A 2021* N/A N/A N/A N/A

Jefferies Group*

Morgan Stanley*

 -
[Planned]
Recbio N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Nayuki Tea Application Submitted* Q2* N/A N/A N/A N/A

CMB*

JPMorgan*

 -
[Planned]
Youran Dairy N/A Q1* N/A N/A N/A N/A

Huatai*

Credit Suisse*

 -
[Planned]
Tencent Music N/A This Year* N/A N/A N/A N/A

Morgan Stanley*

JPMorgan*

 -
[Planned]
JOYY N/A Q3* N/A N/A N/A N/A

N/A

 -
[Planned]
Vipshop N/A Q2* N/A N/A N/A N/A

N/A

 -
[Planned]
Chaoju Eye Care N/A First half of 2021* N/A N/A N/A N/A

Haitong*

Huatai*

 -
[Planned]
JD Logistics Application submitted* 2021Q2-Q3* N/A N/A N/A N/A

Bank of America*

Goldman Sachs*

 -
[Planned]
DIDA CHUXING N/A N/A N/A N/A N/A N/A

Haitong*

Nomura*

 -
[Planned]
DiDi N/A Q3* N/A N/A N/A N/A

Goldman Sachs*

 -
[Planned]
WeDoctor Application Submitted* 1st half of the year* N/A N/A N/A N/A

Citibank*

CMB INTL*

JPM*

Credit Suisse*

CITIC*

 -

# Terms and Conditions Apply

*Market News

：UOB Kay Hian (UOBKH) is one of the participants

Copyright ©, UOB Kay Hian (Hong Kong) Ltd. All rights reserved. Securities & Futures Commission Registered: CE Number AAW261 Client Agreement-Terms & Conditions ( Securities / Futures )